David Gascoigne

David Gascoigne possesses extensive experience in the healthcare analytics and genomics sectors, holding senior leadership roles at various organizations. Currently, David serves as the Chief Executive Officer at Almaden Genomics. Prior positions include Senior Vice President of Healthcare Analytics at Sutherland, Chief Operating Officer at Gene Network Sciences (GNS Healthcare), and General Manager and Vice President of Commercial Analytics at IQVIA. Additionally, David held the role of Executive Vice President for Consulting, Analytics, and Innovation at Symphony Health.